01.
CHG is everywhere.
Chlorhexidine gluconate has become a cornerstone of modern infection control. Its effectiveness against a broad range of bacteria and fungi made it a standard across surgical, dental, and outpatient settings over several decades. Today it is so embedded in routine care that it is often assumed rather than explicitly documented.
In a single episode of care, a patient may encounter CHG multiple times — through different products, administered by different members of a care team — without anyone tracking the cumulative exposure. Each contact looks routine. The interaction is what goes unseen.
Common sources of CHG exposure in healthcare settings:
Pre-surgical skin wipes
Foley catheter lubricants
Arterial line prep solutions
IV site dressings and coatings
Surgical drapes
Wound care products
Dental cleanings and rinses
Antiseptic hand rubs
Outpatient procedural products
Labels do not always disclose CHG clearly. Products may be described as "antiseptic," "medical-grade cleanser," or simply by brand name — leaving patients and even some clinical staff unaware of the active ingredient they are encountering.
Most healthcare workers have never been told that a CHG allergy is even possible. Many will go their entire careers without knowingly encountering a case — which means when one walks through the door, nothing in the room is ready for it.
02.
The skin barrier changes everything.
Healthy, intact skin is a highly effective barrier. It limits the absorption of chemicals and helps regulate immune response. When that barrier is disrupted — even in ways that appear minor or cosmetic — permeability increases and the body's response to chemical exposure can change significantly.
Grooming practices like shaving and waxing are among the most common and least-discussed causes of skin barrier disruption in the perioperative setting. Research has linked shaving before CHG exposure to absorption increases of up to tenfold. Yet intake processes rarely ask about either practice, and clinical guidance has been slow to address the full scope of the risk.
Shaving
Surface disruption
Removes surface hair and can cause micro-cuts and superficial irritation. Barrier disruption is real but typically short-lived. Risk windows are often framed in hours to days.
Waxing
Deeper, longer-lasting disruption
Removes hair from the root, causing subdermal trauma and follicular inflammation. Skin may appear healed while remaining more permeable beneath the surface — for weeks, not days.
This distinction matters clinically. A patient who waxed two weeks before a procedure may show no visible signs of disruption — and yet their skin barrier may still be compromised in ways that meaningfully alter how their body responds to chemical exposure. Current intake processes and safety guidance rarely account for this.
Grooming is treated as cosmetic. The evidence suggests it should be treated as a risk-bearing variable in the perioperative assessment.
Chlorhexidine allergy has no dedicated ICD code. When a reaction occurs, clinicians must file it under a catch-all category — "other anti-infective agents" — alongside dozens of unrelated substances. It cannot be tracked, counted, or flagged. In the data, it simply disappears.
03.
The system isn't designed to see it.
Even when a severe reaction occurs, the healthcare system is not always structured to accurately capture what caused it. CHG allergies are frequently miscoded — attributed to anesthesia, unspecified anaphylaxis, or other more familiar categories. Once miscoded, the information disappears from safety data. The risk is not tracked, not flagged, and not carried forward to protect the next patient.
This is not a failure of individual clinicians. It is a structural problem — the result of systems designed around assumptions that no longer reflect the full scope of risk.
When families search records after a severe reaction, they often find that the relevant exposures were never captured — not because care was careless, but because the system was not designed to look for these interactions in the first place.
What feels unpredictable after the fact is often an untracked variable before it.
-
Standard pre-surgical intake rarely asks about shaving, waxing, or epilation — leaving a key risk variable undocumented before care begins.
-
CHG is often embedded in products not clearly labeled as such, making it difficult for patients and staff to identify cumulative exposure.
-
Clinical records track procedures, not ingredients. Multiple CHG exposures within a single episode of care are rarely captured as discrete events.
-
Reactions are often attributed to broader categories — anesthesia, unspecified anaphylaxis — obscuring CHG as the root cause and preventing pattern recognition over time.
-
Few hospitals have established CHG-free surgical pathways. Even a clearly documented allergy requires cross-department coordination that most facilities aren't built to provide.
For the full systems argument, read The Investigation.
Chlorhexidine allergy doesn't hide because it's rare. It hides because the systems around it — documentation standards, allergy coding, clinical training, surgical protocols — were built without it in mind. A patient can survive a life-threatening reaction, receive a confirmed diagnosis, and still walk into their next procedure carrying a risk no one in the room has been trained to recognize. That is not a knowledge problem any one patient can solve. It is a systems problem. And solving it requires understanding exactly how those systems fail.